Next-generation sequencing (NGS) or massively parallel sequencing is a high-throughput approach to DNA sequencing technologies that can help in the detection of very rare mutations. A time- and cost-effective assay, NGS can be used in a wide spectrum of applications and yield useful information for personalised treatment or targeted therapies.